Somatus is a kidney care company intended to delay or prevent the progression of chronic kidney disease. Founded by Anthony Welters and Ikenna Okezie in 2016, Somatus is backed by investors that include Optum Ventures, Longitude Capital, Flare Capital Partners, The Blue Venture Fund, and Deerfield Management and is headquartered in Mclean.